Evidence map›Paper›PMID 32802183›Full record

ArticleTheranostics2020

Tumor Microenvironment-triggered Nanosystems as dual-relief Tumor Hypoxia Immunomodulators for enhanced Phototherapy.

Zijun Shen, Junfei Xia, Qingming Ma, Wei Zhu, Zhen Gao, Shangcong Han, Yan Liang, Jie Cao, Yong Sun

Open access · goldAbstract read
In one paragraph

Article in Theranostics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 96 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. NIR-responsive CuJournal of nanobiotechnology · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Immune modulations of the tumor microenvironment in response to phototherapy.Journal of innovative optical health sciences · 2023
    Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Zijun ShenDepartment of Pharmaceutics, School of Pharmacy, Qingdao University, Qingdao, China, 266021.
Junfei XiaDepartment of Electrical and Computer Engineering, Tufts University, Medford, MA, 02155.
Qingming MaDepartment of Pharmaceutics, School of Pharmacy, Qingdao University, Qingdao, China, 266021.
Wei ZhuDepartment of Pharmacology, School of Pharmacy, Qingdao University, Qingdao, 266021, China.
Zhen GaoDepartment of Pharmaceutics, School of Pharmacy, Qingdao University, Qingdao, China, 266021.
Shangcong HanDepartment of Pharmaceutics, School of Pharmacy, Qingdao University, Qingdao, China, 266021.
Yan LiangDepartment of Pharmaceutics, School of Pharmacy, Qingdao University, Qingdao, China, 266021.
Jie CaoDepartment of Pharmaceutics, School of Pharmacy, Qingdao University, Qingdao, China, 266021.
Yong SunDepartment of Pharmaceutics, School of Pharmacy, Qingdao University, Qingdao, China, 266021.
Qingdao University · CNTufts University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Photodynamic therapy (PDT) is a promising strategy in cancer treatment that utilizes photosensitizers (PSs) to produce reactive oxygen species (ROS) and eliminate cancer cells under specific wavelength light irradiation. However, special tumor environments, such as those with overexpression of glutathione (GSH), which will consume PDT-mediated ROS, as well as hypoxia in the tumor microenvironment (TME) could lead to ineffective treatment. Moreover, PDT is highly light-dependent and therefore can be hindered in deep tumor cells where light cannot easily penetrate. To solve these problems, we designed oxygen-dual-generating nanosystems MnO

Indexed as

AnimalsCell LineCell Line, TumorFemaleGlutathioneHumansImmunologic FactorsIndocyanine GreenMaleManganese CompoundsMiceMice, Inbred BALB CNanoparticlesOxidesPhotochemotherapyPhotosensitizing AgentsGlutathioneImmunologic FactorsIndocyanine GreenManganese Compoundsmanganese oxideOxidesPhotosensitizing AgentsReactive Oxygen Speciesacute immune responsedual-relief hypoxiaenhanced PDTsynergistic anticancer therapyTumor microenvironment

Identifiers

PMID32802183
PMCPMC7415819
OpenAlexW3044937304

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.